Cosmeceutical compositions comprising a major ampullate spidroin protein (MaSp)-based fiber are disclosed. Articles comprising the compositions are further disclosed.

The present disclosure relates to a polymer complex comprising microcellulose fibers comprising nanofibrils and fine particles; and a polymer matrix. According to the present disclosure, there is provided a polymer complex capable of exhibiting excellent mechanical properties while being environmentally friendly by including cellulose fibers as a reinforcing material.

The invention relates to a method for the production of lyocell staple fibers, comprising the steps in the following order: a) extruding filaments from a solution of cellulose in an organic solvent; b) precipitating the cellulose for the formation of continuous cellulose filaments; c) washing the cellulose filaments; d) contacting the cellulose filaments with a crosslinking agent; e) reacting the cellulose filaments with the crosslinking agent in a reaction chamber; f) washing the treated cellulose filaments; g) cutting the washed cellulose filaments into staple fibers; h) forming a nonwoven fleece from the staple fibers and pressing the nonwoven fleece; and i) finishing the nonwoven fleece and pressing the nonwoven fleece.

A method for supporting repair of soft tissue with biopolymer fibers. Biopolymer is dissolved in acid in a closed container made of materials inert to the acid and to the collagen to form a biopolymer solution. The solution is stirred, then centrifuged to degas it. The degassed solution is put into syringes on a holder. The number of syringes equals the number of fibers in the bundle. The syringes are mounted in a rotatable holder. Essentially equal quantities of degassed solution are extruded from the syringes to produce fibers, which are gathered and fed into a formation buffer bath. The fibers are kept taught after extrusion and dehydrated in a dehydrating solution in a dehydrating bath. The fibers are wound a collector to collect the bundle. The fibers are used to support repair of soft tissue.

The present invention relates to a process for the treatment of lyocell fibers, comprising the step of contacting the fiber with at least one treatment medium, at least one treatment medium containing an amount of a crosslinking agent, wherein the cross-linking agent is capable of crosslinking cellulose under alkaline conditions and has a solubility in water at 20° C. of 20 g/l or less, and further comprising the step of treating the fiber with the cross-linking agent under alkaline conditions, characterized in that the cross-linking agent is added to the fiber in the form of a suspension or in solid form. The present invention also relates to lyocell fibers obtainable by the process of the present invention.

The present invention relates to a process for the treatment of lyocell fibers, comprising the step of contacting the fiber with at least one treatment medium, at least one treatment medium containing an amount of a crosslinking agent, wherein the cross-linking agent is capable of crosslinking cellulose under alkaline conditions and has a solubility in water at 20° C. of 20 g/l or less, and further comprising the step of treating the fiber with the cross-linking agent under alkaline conditions, characterized in that the cross-linking agent is added to the fiber in the form of a suspension or in solid form. The present invention also relates to lyocell fibers obtainable by the process of the present invention.

Disclosed herein are methods of forming a fiber mat, involving forming an aqueous solution of at least one protein, at least one polysaccharide, and optionally a plasticizer, and electrospinning the aqueous solution onto a collector to form a mat.

Disclosed herein are methods of forming a fiber mat, involving forming an aqueous solution of at least one protein, at least one polysaccharide, and optionally a plasticizer, and electrospinning the aqueous solution onto a collector to form a mat.

Grafted, crosslinked cellulosic materials include cellulose fibers and polymer chains composed of at least one monoethylenically unsaturated acid group-containing monomer (such as acrylic acid) grafted thereto, in which one or more of said cellulose fibers and said polymer chains are crosslinked (such as by intra-fiber chain-to-chain crosslinks). Some of such materials are characterized by a wet bulk of about 10.0-17.0 cm3/g, an IPRP value of about 1000 to 7700 cm2/MPa.Math.sec, and/or a MAP value of about 7.0 to 38 cm H2O. Methods for producing such materials may include grafting polymer chains from a cellulosic substrate, followed by treating the grafted material with a crosslinking agent adapted to effect crosslinking of one or more of the cellulosic substrate or the polymer chains. Example crosslinking mechanisms include esterfication reactions, ionic reactions, and radical reactions, and example crosslinking agents include pentaerythritol, homopolymers of the graft species monomer, and hyperbranched polymers.

Grafted, crosslinked cellulosic materials include cellulose fibers and polymer chains composed of at least one monoethylenically unsaturated acid group-containing monomer (such as acrylic acid) grafted thereto, in which one or more of said cellulose fibers and said polymer chains are crosslinked (such as by intra-fiber chain-to-chain crosslinks). Some of such materials are characterized by a wet bulk of about 10.0-17.0 cm3/g, an IPRP value of about 1000 to 7700 cm2/MPa.Math.sec, and/or a MAP value of about 7.0 to 38 cm H2O. Methods for producing such materials may include grafting polymer chains from a cellulosic substrate, followed by treating the grafted material with a crosslinking agent adapted to effect crosslinking of one or more of the cellulosic substrate or the polymer chains. Example crosslinking mechanisms include esterfication reactions, ionic reactions, and radical reactions, and example crosslinking agents include pentaerythritol, homopolymers of the graft species monomer, and hyperbranched polymers.